title: Strategies to reduce risks in ARV supply chains in the developing world.
authors.affiliation: UPS, Columbus, Ohio, USA.
authors.forename: Chris
authors.initials: C
authors.lastname: Larson
authors.affiliation: Management Sciences for Health, Arlington, VA, USA.
authors.forename: Robert
authors.initials: R
authors.lastname: Burn
authors.affiliation: Formerly with the United States Agency for International Development, Washington, DC, USA.
authors.forename: Anja
authors.initials: A
authors.lastname: Minnick-Sakal
authors.affiliation: United States Agency for International Development, Global Health Fellows Program, Washington, DC, USA medouglas@usaid.gov.
authors.forename: Meaghan O'Keefe
authors.initials: MO
authors.lastname: Douglas
authors.affiliation: United States Agency for International Development, Washington, DC, USA.
authors.forename: Joel
authors.initials: J
authors.lastname: Kuritsky
mesh_terms: D044966:Anti-Retroviral Agents / Q000191:economics / Q000600:supply & distribution*; D003906:Developing Countries; D017277:Drug Approval / Q000458:organization & administration; D016568:Drugs, Generic / Q000191:economics / Q000600:supply & distribution; D015658:HIV Infections / Q000188:drug therapy*; D006297:Health Services Accessibility; D006801:Humans
chemical_list: D044966:Anti-Retroviral Agents; D016568:Drugs, Generic